Rex Health Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
BioStable Science & EngineeringinFeb 2020
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.
Austin, US
John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)
Co-investorsLouisiana FundsOrlando Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.